Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zivo Bioscience, Inc.ZIVO · Entity 9611 | Director | January 26, 2026 | January 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zivo Bioscience, Inc.
Report date January 26, 2026 · Filed January 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 279,481 |
Reported balance
After 2026-01-26 transaction · row 1
1 source rowRow 1 · 2026-01-26 · Purchase · Acquired 11,709 · Balance 279,481 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2026 Filed Jan 28, 2026 21:11 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 11,709 | $8.54 | $99,994.86 |
DisclosureSEC source: 0001654954-26-000652 · section16.xml · nonDerivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,481 Read SEC document |
| October 02, 2025 Filed Oct 7, 2025 00:23 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantNonstatutory Stock Options to buy Common Stock · Derivative | 1,223 | $10.20 Strike: $12.03 | $12,474.60 |
DisclosureSEC source: 0001654954-25-011510 · section16.xml · derivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,223 Underlying: Common Stock · 1,223 shares Expires 2035-10-02 F1 · price: This option was issued to the reporting person pursuant to the 2024 Equity Incentive Plan for Non-Employee Directors in lieu of retainer fees of $12,476.71. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock | 8,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-25-000101 · section16.xml · nonDerivative · entry 2 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,772 Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock | 1,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-25-000101 · section16.xml · nonDerivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,491 Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 20:09 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock Purchase Warrants · Derivative | 1,199 | $8.34 Strike: $8.34 | $9,999.66 |
DisclosureSEC source: 0001654954-24-011075 · section16.xml · derivative · entry 2 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,199 Underlying: Common Stock · 1,199 shares Expires 2029-08-22 Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 20:09 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 11,990 | $8.34 | $99,996.60 |
DisclosureSEC source: 0001654954-24-011075 · section16.xml · nonDerivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,975 Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:37 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock | 6,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-24-007746 · section16.xml · nonDerivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,985 Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:27 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Disposition to issuerNonstatutory Stock Option to Purchase Common Stock · Derivative | 3,626 | Not disclosed Strike: $16.74 | Not disclosed |
DisclosureSEC source: 0001654954-24-007462 · section16.xml · derivative · entry 7 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,626 shares Expires 2033-06-11 F1 · derivative.exercise_price: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F1 · shares: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F3 · price: The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock. F4 · derivative.exercise_date: The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 6/12/2023 and vested as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:27 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Disposition to issuerNonstatutory Stock Option to Purchase Common Stock · Derivative | 23,240 | Not disclosed Strike: $15.66 | Not disclosed |
DisclosureSEC source: 0001654954-24-007462 · section16.xml · derivative · entry 6 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,240 shares Expires 2032-12-18 F1 · derivative.exercise_price: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F1 · shares: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F3 · price: The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock. F2 · derivative.exercise_date: The canceled options were fully vested. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:27 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Disposition to issuerNonstatutory Stock Option to Purchase Common Stock · Derivative | 707 | Not disclosed Strike: $17.16 | Not disclosed |
DisclosureSEC source: 0001654954-24-007462 · section16.xml · derivative · entry 5 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 707 shares Expires 2032-12-15 F1 · derivative.exercise_price: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F1 · shares: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F3 · price: The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock. F2 · derivative.exercise_date: The canceled options were fully vested. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:27 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Disposition to issuerNonstatutory Stock Option to Purchase Common Stock · Derivative | 2,632 | Not disclosed Strike: $21.66 | Not disclosed |
DisclosureSEC source: 0001654954-24-007462 · section16.xml · derivative · entry 4 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,632 shares Expires 2032-07-27 F1 · derivative.exercise_price: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F1 · shares: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F3 · price: The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock. F2 · derivative.exercise_date: The canceled options were fully vested. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:27 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Disposition to issuerNonstatutory Stock Option to Purchase Common Stock · Derivative | 3,179 | Not disclosed Strike: $26.88 | Not disclosed |
DisclosureSEC source: 0001654954-24-007462 · section16.xml · derivative · entry 3 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,179 shares Expires 2031-10-11 F1 · derivative.exercise_price: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F1 · shares: The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. F3 · price: The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock. F2 · derivative.exercise_date: The canceled options were fully vested. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:27 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock | 95,134 | $7.96 | $757,266.64 |
DisclosureSEC source: 0001654954-24-007462 · section16.xml · nonDerivative · entry 2 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,712 Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:27 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock | 60,724 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-24-007462 · section16.xml · nonDerivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,578 F3 · price: The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 21:16 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock | 37,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-24-007348 · section16.xml · nonDerivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,854 Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:05 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 41,666 | $1.20 | $49,999.20 |
DisclosureSEC source: 0001654954-24-000193 · section16.xml · nonDerivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,666 Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 21:05 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantNonstatutory Stock Option to Purchase Common Stock · Derivative | 21,756 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001654954-23-008024 · section16.xml · derivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,756 Underlying: Common Stock · 21,756 shares Expires 2033-06-11 F1 · derivative.exercise_date: The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date. Read SEC document |
| December 19, 2022 Filed Dec 21, 2022 21:58 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantNonstatutory Stock Option to Purchase Common Stock · Derivative | 139,444 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001654954-22-016816 · section16.xml · derivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,444 Underlying: Common Stock · 139,444 shares Expires 2032-12-18 F1 · derivative.exercise_date: The option was issued pursuant to the 2021 Equity Incentive Plan and vested immediately upon grant. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantNonstatutory Stock Option to Purchase Common Stock · Derivative | 4,244 | $0.00 Strike: $2.86 | $0.00 |
DisclosureSEC source: 0001654954-22-016734 · section16.xml · derivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,244 Underlying: Common Stock · 4,244 shares Expires 2032-12-15 F1 · derivative.exercise_date: The option was issued pursuant to the 2021 Equity Incentive Plan and vested immediately upon grant. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 21:16 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 12,000 | $3.00 | $36,000.00 |
DisclosureSEC source: 0001654954-22-016511 · section16.xml · nonDerivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.965 to $3.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 20:40 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantNonstatutory Stock Option to Purchase Common Stock · Derivative | 15,797 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001654954-22-010399 · section16.xml · derivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,797 Underlying: Common Stock · 15,797 shares Expires 2032-07-27 F1 · derivative.exercise_date: The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date. Read SEC document |
| October 12, 2021 Filed Oct 16, 2021 01:16 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantNonstatutory Stock Option to Purchase Common Stock · Derivative | 19,076 | $0.00 Strike: $4.48 | $0.00 |
DisclosureSEC source: 0001654954-21-011166 · section16.xml · derivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,076 Underlying: Common Stock · 19,076 shares Expires 2031-10-11 F1 · derivative.exercise_date: The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2022 Annual General Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 19:49 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock Purchase Warrant · Derivative | 15,000 | $0.01 Strike: $5.50 | $150.00 |
DisclosureSEC source: 0001078782-21-000535 · primary_doc.xml · derivative · entry 2 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2026-06-02 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 19:49 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | PurchaseCommon Stock | 15,000 | $4.99 | $74,850.00 |
DisclosureSEC source: 0001078782-21-000535 · primary_doc.xml · nonDerivative · entry 1 Cornell Alison A · CIK 0001549395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.